The bottom line? Its called Net Cash From OPERATING Activities.
This encompasses the business operation and its operating cash costs so that is why you simply need to use Dec Quarter's $5.2mil merchant payout + circa $600k TTV generated which forms the cash receivables due back over the March 2022 quarter.
Addback $5.8mil Dec Qtr Receivables onto the Year to Date Loss of -$11.77mil for a Year To Date Cash loss of -$5.9mil
The ONLY receivables still to come in would be the circa $5.8mil Dec quarter merchant payouts + TTV. All other prior quarter receivables are already receipted as part of the $8mil.
So that is how it should be adjusted.
This is assuming the $11.77mil Year to Date Cash Loss includes all business expenses but that is rarely the case as there would be accrued expenses which had no cashflow effect yet so is not showing in this Dec Quarter cashflow report , but it hopefully is not substantial we can ignore.
- Forums
- ASX - By Stock
- OVT
- Ann: December 2021 Quarterly Report and Business Update
Ann: December 2021 Quarterly Report and Business Update, page-120
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
-0.008(19.5%) |
Mkt cap ! $73.08M |
Open | High | Low | Value | Volume |
4.3¢ | 4.4¢ | 3.1¢ | $5.941M | 163.1M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1502325 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 4705093 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 2504930 | 0.032 |
23 | 6045130 | 0.031 |
28 | 3086501 | 0.030 |
15 | 3775931 | 0.029 |
14 | 2035643 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 389231 | 4 |
0.034 | 4545813 | 14 |
0.035 | 4111389 | 10 |
0.036 | 4785650 | 13 |
0.037 | 8902783 | 8 |
Last trade - 13.03pm 13/11/2024 (20 minute delay) ? |
Featured News
OVT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online